发明授权
US06232337B1 Selective &bgr;3 adrenergic agonists 失效
选择性β3肾上腺素激动剂

Selective &bgr;3 adrenergic agonists
摘要:
The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective &bgr;3 receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and methods of treating Type II diabetes and obesity, comprising administering to a mammal in need thereof compounds of formula (I) or a pharmaceutically acceptable salt thereof. The variables of formula (I) have the meanings defined herein.
信息查询
0/0